Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, has emerged as one of the most common causes of chronic liver disease in developed countries over the last decade. NAFLD comprises a spectrum of pathological hepatic changes, including steatosis, steatohepatitis, advanced fibrosis, and cirrhosis. Autophagy, a homeostatic process for protein and organelle turnover, is decreased in the liver during the development of NAFLD. Previously, we have shown that carbon monoxide (CO), a reaction product of heme oxygenase (HO) activity, can confer protection in NAFLD, though the molecular mechanisms remain unclear. We therefore investigated the mechanisms underlying the protective effect of CO on methionine/choline-deficient (MCD) diet-induced hepatic steatosis. We found that CO induced sestrin-2 (SESN2) expression through enhanced mitochondrial ROS production and protected against MCD-induced NAFLD progression through activation of autophagy. SESN2 expression was increased by CO or CO-releasing molecule (CORM2), in a manner dependent on signaling through the protein kinase R-like endoplasmic reticulum kinase (PERK), eukaryotic initiation factor-2 alpha (eIF2α)/ activating transcription factor-4 (ATF4)-dependent pathway. CO-induced SESN2 upregulation in hepatocytes contributed to autophagy induction through activation of 5'-AMP-activated protein kinase (AMPK) and inhibition of mechanistic target of rapamycin (mTOR) complex I (mTORC1). Furthermore, we demonstrate that CO significantly induced the expression of SESN2 and enhanced autophagy in the livers of MCD-fed mice or in MCD-media treated hepatocytes. Conversely, knockdown of SESN2 abrogated autophagy activation and mTOR inhibition in response to CO. We conclude that CO ameliorates hepatic steatosis through the autophagy pathway induced by SESN2 upregulation.
Introduction
Non-alcoholic fatty liver disease (NAFLD), a chronic liver disease with increasing incidence worldwide [1] , represents a hepatic manifestation of metabolic syndrome with potential progression to steatohepatitis, cirrhosis, and hepatocellular carcinoma [2] [3] [4] . Although the pathogenesis of NAFLD remains incompletely understood, the accumulation of hepatic triglycerides (TGs), due to imbalance between the synthesis and lipolysis of TGs, may contribute to its progression [5] . Thus, the modulation of TG synthesis or lipolysis may represent a potential therapeutic strategy for NAFLD.
Autophagy, a cellular homeostatic process for protein and organelle turnover, may be intimately involved in the pathogenesis of NAFLD [6] . The progression of NAFLD is associated with reduced autophagy function in both ob/ob and high fat diet (HFD)-fed mice. Inhibition of autophagy increased TG storage in lipid droplets in cultured hepatocytes and mouse liver. Furthermore, HFD-fed mice with hepatocyte-specific deletion of the autophagy-related protein-7 (Atg7) gene developed marked accumulation of hepatic TGs and cholesterol; whereas enhancing autophagy by Atg7 overexpression improved hepatic steatosis and insulin resistance in ob/ob mice and HFD-fed mice [7, 8] . In addition, impaired hepatic autophagic flux was observed in mice with methionine-choline deficient (MCD) diet-induced hepatic steatosis, and in patients with advanced NAFLD (non-alcoholic steatohepatitis, NASH) [9] . The pharmacological promotion of autophagy by carbamazepine or rapamycin alleviated steatosis and injury in HFD-fed mice [10] . Thus, increasing autophagy with pharmacological agents may offer a new therapeutic approach to NAFLD.
Sestrin-2 (SESN2), a member of the highly conserved stress-inducible sestrin family, exhibits oxidoreductase activity in vitro and regulates major cellular processes including cell viability, antioxidant defenses, cell growth and metabolism [11] [12] [13] [14] . Sestrin induction results in the inhibition of mTOR complex 1 (mTORC1) activity through either AMPK stimulation or inhibition of its lysosomal localization [15] . Sestrins are induced by various stress insults via the stress-responsive transcription factors (TFs) p53 and FoxO [16, 17] . SESN2 expression is regulated by endoplasmic reticulum (ER) stress-activated TFs such as ATF4 [18] , c/EBPβ [19] , and Nrf2 [20] . Once induced, SESN2 maintains hepatic ER homeostasis by suppressing mTORC1-dependent protein translation [19] . Thus, the SESN2-mediated unfolded protein response (UPR) can exert protective functions against ER stress-associated diseases.
Carbon monoxide (CO) is a low molecular weight gas with therapeutic potential when applied exogenously at low concentration. CO functions as a gasotransmitter when produced endogenously via the catabolism of heme by inducible heme oxygenase-1 (HO-1). The upregulation of HO-1, and consequently, endogenous CO production, responds to numerous biological stresses, namely hypoxia, hyperoxia, hypothermia, ER stress and ischemia [21, 22] and thereby couples cellular homeostatic and cytoprotective defenses with the activation of anti-inflammatory, antioxidant, unfolded protein and mitochondrial quality control responses [23] [24] [25] [26] [27] [28] . Low-dose exogenous CO treatment has been shown to also protect against a wide range of pathological conditions, including local and systemic inflammation [29] [30] [31] , oxidative stress [32] [33] [34] , ischemia/reperfusion injury [35, 36] , sepsis [37, 38] , and acute lung injury [39, 40] . Recently, the HO-1/CO system has also been implicated as a modulator of obesity and associated metabolic disease, though the underlying mechanisms remain incompletely understood. The goal of the present study was to elucidate the molecular mechanisms responsible for the beneficial effects of exogenously-applied CO on hepatic steatosis.
Materials and methods

Reagents
Tricarbonyldichlororuthenium (II) dimer (CORM2), N-acetyl-L-cysteine (NAC), (2-(2,2,6,6-Tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl)triphenylphosphonium chloride (Mito-TEMPO), Rotenone, and bafilomycin A1 were from Sigma-Aldrich (St Louis, MO, USA).
Cell culture
AML12 mouse hepatocytes (ATCC; CRL-2254) were maintained in Dulbecco's modified Eagle's medium (DMEM/F12; GIBCO, Grand Island, NY) supplemented with 10% heat-inactivated fetal bovine serum and 1% penicillin/streptomycin (P/S) (GIBCO medium supplemented with 10% FBS, 1% MEM non-essential amino acid solution, 2.2 μl β-mercaptoethanol, and 1% P/S. All cells were incubated at 37°C with 100% humidity in 5% CO 2 and passaged using standard cell culture techniques. For the cellular NAFLD model, cells were incubated in methionine/choline-deficient (MCD) medium (DMEM/nutrient mixture F12 1:1 without L-methionine and choline chloride; GIBCO) supplemented with 10% FBS and 1% P/S solution.
Plasmids and siRNA transfection
pEGFP-LC3 was a gift from Tamotsu Yoshimori (Addgene plasmid #21073). Cells were transfected with pEGFP-LC3, Sesn2 siRNA (sc-153380, Santa Cruz Biotechnology, Santa Cruz, CA), Perk siRNA (sc-36214, Santa Cruz), or scramble siRNA (scRNA) (AM4611, Ambion, Austin, TX) using Lipofectamine™ 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. After 24 h, plasmid-or siRNA-transfected cells were assayed by fluorescence microscopy, and siRNA-transfected cells were harvested for qRT-PCR or immunoblotting.
Animal experiments
All experiments with mice were approved by the Animal Care Committee of the University of Ulsan. C57BL/6 mice (6 weeks old, male) were purchased from ORIENT (Busan, Korea). Liver-specific eIF2α S/S WT and eIF2α A/A mutant mice were provided by Sung Hoon Back (University of Ulsan, Korea). The mice were maintained under specific pathogen-free conditions at 22°C and given access to food and water ad libitum. For the NAFLD mouse model, mice were fed with methionine and choline-deficient (MCD) diet (#518810, Dyets Inc, Bethlehem, PA) for 3 weeks. Mice inhaled air or CO at 250 ppm (ppm) in air (Core Gas Ulsan, Korea) for 2 h/day in a sealed exposure chamber (LB Science, Daejeon, South Korea) at room temperature for the indicated days or weeks. CO concentrations in the chamber were monitored by a CO probe (Tongoy Control Technology, Beijing, China).
Isolation of primary hepatocytes
Primary hepatocytes were isolated from mice by collagenase digestion and by the two-step Percoll gradient method with slight modifications. Mice were anesthetized, and the peritoneal cavity was opened. Livers were perfused with Ca 2+ and Mg 2+ -free Hank's buffered salt solution (HBSS) (GIBCO) containing EGTA (2.5 mM) and then digested with a solution containing collagenase (0.5 mg/ml, C5138, Sigma), NaCl (66.7 mM), KCl (6.7 mM), HEPES (50 mM), and CaCl 2 (4.8 mM). Digested livers were dissected and then gently teased with forceps until they were in solution. The cell suspensions were filtered through a 100-μm nylon cell strainer (BD Falcon, Corning NY). The cells were centrifuged for 5 min at 1900 rpm and then resuspended with HBSS. After the cell suspensions were centrifuged for 3 min at 450 rpm, the pellets (containing parenchymal cells such as hepatocytes) were resuspended with HBSS. The pellet suspensions obtained as described above were centrifuged using 25% Percoll for 5 min at 800 rpm with the brake option off. The cell pellets were washed with DMEM supplemented with 10% FBS, and then the cells were seeded into a collagen pre-coated 100 mm tissue culture plates. After 24 h, non-adherent cells were removed by aspiration, and fresh media were added.
Hepatocellular damage assay
To detect serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), serum was collected from peripheral blood. ALT and AST activity, indicators of hepatocellular injury, were measured using the EnzyChrom™ Alanine Transaminase Assay Kit and EnzyChrom™ Aspartate Transaminase Assay Kit (BioAssay System, Hayward, CA).
Measurement of hepatic triglycerides
Hepatic triglycerides (TGs) were assessed using the TG colorimetric assay kit (Cayman Chemical, Ann Arbor, MI). Briefly, liver tissues (50 mg) and cells (1 × 10 7 ) were homogenized in diluted Standard Diluents. After centrifugation for 10 min at 10,000 × g, supernatants were obtained. Before assaying, tissue samples required dilutions of at least 1:5, and 10 μl supernatant was used for the assay. For cell lysates, protein concentration was measured with the BCA protein assay, and then samples containing 50 μg protein were used for the measurement of TGs.
Quantitative real-time RT-PCR (qRT-PCR) and RT-PCR
Total RNA was isolated from cells using Trizol Reagent (Invitrogen) according to the manufacturer's protocol. RNA was reverse transcribed to synthesize the first-strand cDNA by using oligo-dT primers (QIAGEN, Hilden, Germany) and M-MLV reverse transcriptase (Promega) according to the manufacturer's instructions. The cDNA product was subjected to the PCR-based amplification. Semi-quantitative RT-PCR was performed using Taq polymerase (Bioneer, Daejeon, South Korea). Real-time PCR was performed using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) on an ABI 7500 Fast Real-Time PCR System (Applied Biosystems). Real-time PCR primer pairs were as follows: SESN2: 5′-TAG CCT GCA GCC TCA CCT AT -3′, 5′-TAT CTG ATG CCA AAG ACG CA -3′; actin: 5′-AGA GGG AAA TCG TGC GTG AC -3′, 5′-CAA TAG TGA TGA CCT GGC CGT -3′; GAPDH: 5′-GGG AAG CCC ATC ACC ATC T-3′, 5′-CGG CCT CAC CCC ATT TG-3′. mRNA expression data were normalized to β-actin or GAPDH gene expression.
SDS-PAGE analysis and immunoblotting
Harvested liver tissues and cells were lysed with mammalian lysis buffer or RIPA buffer containing phosphatase and protease inhibitors. Protein content of cell lysates was measured with the BCA protein assay reagent (Pierce Biotechnology, Rockford, IL), and samples containing equal amounts of protein were used for analysis. Lysates were boiled in sample buffer containing β-mercaptoethanol for 5 min. Proteins were then subjected to SDS-PAGE and transferred to polyvinylidene difluoride membranes (GE Healthcare, Waukesha, WI). After blocking with 5% skim milk in PBS, membranes were incubated with appropriate dilutions of antibodies at 4°C overnight as follows: phospho-PERK (Thr 981) (12814, Signalway antibody, College Park, MD), PERK (#3192, Cell Signaling Technology, Danvers, MA), p-eIF2α (Ser 51) (#9721, Cell Signaling), eIF2α (sc-11386, Santa Cruz), ATF4 (10835-1-AP, Proteintech, Chicago, IL), SESN2 (10795-1-AP, Proteintech, Chicago, IL, CA), LC3B (2220, Novus Biologicals, Littleton, CO), Beclin 1 (612113, BD Biosciences, San Jose, CA), Atg7 (#2631, Cell Signaling Technology, Danvers, MA), phospho-AMPKα (T172) (#2535, Cell Signaling), phospho-p70S6K (Thr389) (#9234, Cell Signaling), phospho-S6 (S235/S236) (#4856, Cell Signaling), phospho-ULK1 Ser757 (#6888, Cell Signaling), p53 (#1026-1, Epitomics), α-tubulin (#2144, Cell Signaling), and β-actin (#4967S, Cell Signaling) were used. Membranes were then washed with PBS supplemented with 0.05% Tween-20 and incubated with a 1/5000 dilution of HRP conjugated secondary Abs at room temperature for 1 h. Immunoreactivity was detected using the ECL detection system (GE Healthcare) and chemiluminescence signal was read with an Azure Biosystems C300 analyzer (Azure Biosystems, Inc., Dublin, CA).
Mitochondrial ROS measurement by FACS
Cells were grown to 80% confluence and fresh media before the experiments. Cells were treated with CORM2 (20 μM) (A and B) or CO gas (250 ppm) (C and D) for 2 h in the absence or presence of Mito-TEMPO (100 μM) or NAC (1 mM). After treatment, add MitoSOX Red (5 μM) and incubate cells in the dark for 30 min at 37 ℃. The cells were trypsinized and placed cells in FACS tube. And then, cells were washed three times with PBS and then dilute samples to a final volume of 500 μl with FACS buffer. MitoSOX fluorescence was detected by FACSCanto™ flow cytometry system (BD Biosciences). Data were analyzed using FlowJo software (version 10).
Fluorescence microscopy
Cells were plated on a 4-well Lab-Tek chambered coverglass (Nunc, Thermo Scientific, Waltham, MA) and transfected with pEGFP-LC3 plasmid and siRNA. After 24 h, cells were treated with 20 μM CORM2 for 4 h. Cells were washed in PBS, fixed with 4% paraformaldehyde in PBS at room temperature for 10 min, and the washed with PBS, and then stained with 1 μg/ml DAPI (Sigma, D9542) for 20 min. The samples were washed with PBS. GFP-LC3 puncta were imaged with an Olympus FV1200 confocal microscope (Olympus, Tokyo, Japan).
Hematoxylin and eosin (H & E) staining
For histopathological observations, portions of liver were fixed in 10% neutral-buffered formalin solution and then dehydrated in graded alcohol. The fixed tissue was embedded in paraffin and sliced into 4-μm-thick sections. Tissue sections were mounted on regular glass slides, deparaffinized in xylene, rehydrated in decreasing concentrations of ethanol, and stained with hematoxylin and eosin (H & E).
Statistical analysis
All data were expressed as mean ± SEM. Differences between experimental groups were compared using the Student's two-tailed t-test.
Results
CO increases SESN2 expression in liver cells and tissues
To investigate the effects of CO on SESN2 expression, we treated the mouse hepatocyte cell line AML12 with a CO-releasing molecule (CORM2) at various concentrations and time intervals. CORM2 doseand time-dependently induced Sesn2 mRNA expression (Fig. 1A and B) , and SESN2 protein expression ( Supplementary Fig. 1A ) in AML12 cells. Similarly, exposure to CO gas (250 ppm) increased Sesn2 mRNA expression in AML12 cells and primary hepatocytes (Fig. 1C and D) . To determine the effect of CO on SESN2 induction in mouse liver in vivo, mice were subjected to CO inhalation (250 ppm, 2 h/day for 7 days). Inhaled CO induced Sesn2 expression in the liver beginning at day 1, which increased until day 3 (Fig. 1E ). These data demonstrate that CO can increase Sesn2 gene expression in hepatocytes and liver tissues.
Previous reports have shown that CO acts via inhibition of mitochondrial cytochrome c oxidase leading to the generation of low levels of reactive oxygen species (ROS), and that mitochondrial stress can lead to the activation of adaptive signaling pathways [41] . We therefore investigated whether SESN2 induction by CO was associated with modulation of ROS production. CORM2 or CO gas induced Sesn2 mRNA expression in AML12 cells, which was significantly inhibited by treatment with the ROS scavenger N-acetyl-L-cysteine (NAC) or the mitochondria-targeted antioxidant Mito-TEMPO (Fig. 1F-I ). As shown in Fig. 1 . SESN2 was upregulated by carbon monoxide (CO) in liver cells and tissue. AML12 cells were treated with CORM2 for 1 h at the indicated concentrations (A), or for the indicated times at 20 μM (B). AML12 cells (C) or primary hepatocytes (D) were incubated with CO (250 ppm) for the indicated times. Cells were harvested and total RNA was analyzed by qRT-PCR for Sesn2 gene expression levels. (E) C57BL/6 mice were exposed to CO (250 ppm for 2 h/day for 7 days). The gene expression of Sesn2 was evaluated by qRT-PCR in livers of mice (N=4/group) at the indicted days. (F-I) AML12 cells were pretreated with 20 μM CORM2 (F and H) or exposed to CO (250 ppm) (G and I) in the presence or absence of NAC (3 mM) or Mito-TEMPO (100 μM). At the indicated times, the gene expression of Sesn2 was determined by qRT-PCR. (J and K) AML12 cells were treated with CORM2 (20 μM) (J) or CO gas (250 ppm) (K) for 2 h in the absence or presence of Mito-TEMPO (100 μM) or NAC (1 mM) with MitoSOX Red and analyzed by flow cytometry. Rotenone was used as a positive control for mitochondrial ROS production. (L and M) AML12 cells were treated with CORM2 (20 μM) (L) or CO gas (250 ppm) (M) for 1 h in the absence or presence of Mito-TEMPO (100 μM). After treatment, cells were lysed and analyzed by immunoblotting using antibodies against phosphorylated (p)-PERK, PERK, p-eIF2α, eIF2α, ATF4, and actin. β-actin was the standard. Data represent mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, n.s., not significant.
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Fig. 1J-K, CORM2 or CO gas-induced mitochondrial ROS production, as detected with MitoSox Red. ROS generated by mitochondrial stress has been reported to activate the protein kinase-like ER kinase (PERK)/ eukaryotic initiation factor-2 alpha (eIF2α)/ activating transcription factor-4 (ATF4) signaling pathway [42] . CORM2 or CO stimulated the activation of PERK pathway, as shown by increased expression of PERK, which could be inhibited by the mitochondria-targeted antioxidant Mito-TEMPO ( Fig. 1L and M) . These results suggest that CO enhanced the expression of SESN2 through promotion of ROS.
3.2. CO increases SESN2 expression through a PERK/eIF2α/ATF4 dependent pathway SESN2 regulation has been demonstrated to occur via p53-dependent and independent mechanisms [43] . Thus, we examined whether SESN2 upregulation by CO was p53-dependent. Human HepG2 hepatoma cells expressing WT p53 displayed SESN2 up-regulation after CO exposure. Increased SESN2 expression was also detected in cells lacking wild-type p53 (Hep3B) after CORM2 treatment ( Supplementary Fig. 1B  and C) . Collectively, these data suggest that CO can induce the expression of SESN2 independent of p53 status.
To investigate the mechanism by which CO leads to an increase in SESN2 expression, we determined the contribution of each signaling arm of the UPR. Knockdown of PERK using siRNA decreased the CORM2-induced increase in Sesn2 mRNA ( Supplementary Fig. 2A ). In addition, we examined SESN2 expression following CORM2 treatment in cells functionally deficient in the three branches of the UPR (PERK/ eIF2α/ATF4; IRE1α; and ATF6). Perk -/-MEF cells displayed lower Sesn2 mRNA expression upon CO treatment compared to their WT (Perk +/+ ) counterparts ( Fig. 2A) . Likewise, eIF2α A/A (homozygous for the S51A mutation) and Atf4 -/-hepatocytes displayed a significant reduction in CO-induced Sesn2 mRNA expression compared to corresponding WT eIF2α S/S and Atf4 +/+ hepatocytes. In contrast, CO-dependent expression of Sesn2 mRNA in CO-treated Ire1α -/-and Atf6 -/-hepatocytes was similar to that of the corresponding WT cells ( Supplementary Fig. 2B and C). Furthermore, we determined the effect of inhaled CO on Sesn2 upregulation in the liver of eIF2α A/A mice, and in primary hepatocytes derived from these mice. CO inhalation in eIF2α A/A mice had no effect on hepatic Sesn2 mRNA expression compared to robust induction observed in WT mice (Fig. 2D) . Similarly, CO treatment had no effect on hepatic Sesn2 mRNA expression in primary hepatocytes isolated from eIF2α A/A mice (Fig. 2E) . Taken together, these findings suggest that the PERK/eIF2α/ATF4 branch of the UPR plays a crucial role in mediating CO-induced SESN2 expression.
3.3. CO-mediated SESN2 upregulation contributed to autophagy enhancement through AMPK activation and mTOR inhibition SESN2 can regulate mTOR in response to various stimuli, and acts as a positive regulator of autophagy [44] . Thus, we investigated whether SESN2 upregulation by CO contributed to the maintenance of autophagy activity. CORM2 significantly increased LC3B-II protein levels in AML12 (Fig. 3A) , HepG2 and Hep3B cells ( Supplementary Fig. 3A and B). To determine whether CO-induced accumulation of LC3B-II was caused by enhanced formation of autophagic vacuoles, or the blockage of autophagic vacuole degradation, we treated hepatocytes with CORM2 in the absence or presence of NH 4 Cl or Bafilomycin A1, an inhibitor of lysosomal degradation. The CO-dependent elevation in LC3B-II levels was further increased after treatment with NH 4 Cl or Bafilomycin A1, indicative of active autophagic flux in these cells ( Supplementary Fig. 3C and D) .
SESN2 forms a complex with AMPK, which in active form is required for negative regulation of mTOR by SESN2 [43] . We next confirmed whether AMPK activation and mTOR activity were influenced by SESN2. As shown in Fig. 3B , the amounts of SESN2 and phosphorylated AMPK (Thr172) protein increased after treating AML12 cells with CORM2 for 2 h. In contrast, phosphorylation of the mTORC1 targets p70S6K (p70S6K) (T389) and S6 ribosomal protein (S6RP) (S235/236) were significantly decreased in CORM2-treated AML12 cells at 2 h post treatment.
We next examined LC3B distribution following CORM2 treatment in GFP-LC3B transfected hepatocytes, using fluorescence microscopy. CORM2 treatment (4 h) increased LC3B puncta formation, an indicator of autophagosome formation, in GFP-LC3B expressing hepatocytes, The gene expression of Sesn2 was quantified by qRT-PCR. Data represent mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
relative to untreated cells (Fig. 3C) . Transfection of hepatocytes with Sesn2-specific siRNA efficiently lowered SESN2 protein levels and abrogated SESN2 upregulation induced by CORM2 (Fig. 3D ). SESN2 knockdown markedly reversed the induction of LC3B-II levels, and also significantly abrogated AMPK activation in response to CORM2, resulting in reversal of mTORC1 inhibition, and increased p70S6K phosphorylation (Fig. 3D) . To determine whether SESN2 contributed to CO-induced autophagy, GFP-LC3B puncta were examined in control and Sesn2 siRNA-transfected AML12 cells. Consistent with the elevation in LC3B-II protein, treatment with CO significantly increased the number of LC3B puncta in cells transfected with control scRNA. Knockdown of SESN2 inhibited autophagosome formation (as determined by puncta formation) in CORM2-treated GFP-LC3B expressing cells (Fig. 3E) . Taken together, these data demonstrated that SESN2 upregulation by CO contributed to autophagy enhancement through the AMPK-mTORC1 axis.
CO attenuates liver damage in mice fed a methionine-choline-deficient (MCD) diet
We next examined whether CO inhalation can protect against liver injury during the progression of experimental NAFLD in mice. CO inhalation reduced hepatic lipid accumulation and inflammatory infiltration (Fig. 4A) , liver TG content (Fig. 4B) , and hepatic injury markers ( Fig. 4C and D) compared to those of the control (air inhalation) group. Previously, it has been reported that NASH patients or MCD diet-fed mice displayed elevated expression of the ER stress marker C/EBP homologous protein (CHOP) and increased hepatic inflammation. We observed that CO reduced the levels of CHOP, TNF-α, and IL-1β expression in MCD-diet fed mice ( Supplementary Fig. 4A and  B ). These data demonstrate that CO can attenuate MCD diet-induced liver damage in mice.
CO induces SESN-2 and enhances autophagy through the AMPK/ mTORC1 axis in the liver of MCD diet-fed mice
Enhanced autophagy may reduce lipid accumulation by regulating lipid metabolism, as proposed by Singh et al. [7] . Hence, we hypothesized that autophagy may contribute to the beneficial effect of CO in MCD diet-fed mice. Interestingly, we found that CO inhalation markedly increased autophagy indicators in the liver of MCD-diet fed mice, as evidenced by increased LC3B-II, Beclin 1, and Atg-7 protein levels (Fig. 5A ). Hepatic SESN2 (mRNA and protein) expression levels were also significantly increased by CO inhalation in MCD-diet fed mice ( Fig. 5B and C) . We next investigated whether CO activated autophagy in vivo through regulation of the AMPK/mTORC1 axis [45] [46] [47] . The phosphorylation of AMPK (Thr172) was increased in the liver of MCDdiet fed mice subjected to CO inhalation (Fig. 5D) . In contrast, the phosphorylation of ULK1 (Ser757), p70S6K (T389), and S6RP (S235/ 236), downstream targets of mTOR signaling, were decreased by CO. These data suggest that CO-induced SESN2 enhances autophagy through AMPK activation and mTORC1 inhibition in the MCD diet-fed mouse model.
CO-induced SESN2 upregulation activates autophagy through the AMPK/mTORC1 axis in a cellular model of NAFLD
To evaluate the effects of CO in an in vitro model of NAFLD, we treated hepatocytes with MCD medium. LC3B-II levels were markedly decreased, whereas the expression of phosphorylated p70S6K was increased in MCD medium-treated cells (Supplementary Fig. 5 ). AML12 cells were treated with CORM2 in the presence of MCD or control After 4 h, cells were fixed and analyzed for LC3B puncta (green) using a confocal fluorescence microscope. Nuclei were stained with DAPI (blue). (D) AML12 cells were transfected with control siRNA (scRNA) or Sesn2-specific siRNA (siSESN2) for 24 h and then treated with the indicated dose of CORM2 for 4 h. Cells were harvested and lysates were analyzed by immunoblotting for SENS2, LC3B, p-AMPK, p-p70S6K (T389) and β-actin. (E) AML12 cells were co-transfected with pEGFP-LC3 plasmids and scRNA or Sesn2 siRNA for 24 h and then treated with CORM2 (20 μM) for 4 h. LC3B puncta (green) were analyzed using a confocal fluorescence microscope. Nuclei were stained with DAPI (blue). The number of LC3B puncta per cell was calculated in 20 randomly chosen cells. Data represent mean ± SEM. **P < 0.01, ***P < 0.001.
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medium for 24 h. CORM2 treatment significantly decreased TG levels in MCD medium-treated cells (Fig. 6A) . Furthermore, CORM2 increased mRNA and protein levels of SESN2 ( Fig. 6B and C) , LC3B-II levels, and phosphorylation of AMPK (Tyr172), but decreased phosphorylation of Ulk1 (Ser757) and p70S6K (T389) in MCD-treated AML12 cells (Fig. 6D) .
To further explore the relationship between CO-induced SESN2 expression and autophagy in the cellular NAFLD model, we inhibited SESN2 expression using Sesn2-specific siRNA. As shown in Fig. 6E , siRNA-dependent downregulation of SESN2 abrogated CO-induced SESN2 expression and LC3B-II levels and decreased CO-induced phosphorylation of AMPK (Tyr172) relative to control (scRNA-transfected) cells. In contrast, the suppression of ULK and p70S6K phosphorylation by CORM2 was reversed by Sesn2-specific siRNA transfection relative to control (scRNA-transfected) cells. In addition, CO inhibited MCD-induced TG levels, while these effects were abolished by SESN2 knockdown (Fig. 6F) .
Confocal analysis of GFP-LC3 transfected hepatocytes revealed that CORM2 treatment increased the number of LC3B puncta in cells cultured in MCD-medium. However, Sesn2-specific siRNA transfection significantly decreased CO-induced LC3B puncta in MCD-media cultured cells (Fig. 6G) . These data taken together, demonstrate that CO increases SESN2 expression which mediates AMPK activation and mTORC1 inhibition, which in turn restores impaired autophagy in cells cultured in MCD medium.
Discussion
CO can confer tissue protection in a number of animal organ and tissue injury models, when applied exogenously at low concentration. Furthermore, CO can arise endogenously as the product of heme oxygenase-1 (HO-1, encoded by the Hmox1 gene) enzymatic activity, which catalyzes the rate-limiting step in the metabolic conversion of heme to bilirubin-IXα, iron, and CO [22] . Although CO is relatively inert in biological systems, with reactivity restricted to iron centers, both exogenous and endogenously-produced CO can activate signal transduction pathways affecting critical cellular processes including inflammation, cellular proliferation and apoptosis. These effects of CO are known to be mediated via multiple pathway mechanisms, including activation of soluble guanylate cyclase (sGC), p38 mitogen-activated protein kinase (p38 MAPK), and potassium channels. Previously, we reported that exogenous CO administration can induce HO-1 in human endothelial cells. HO activity, in turn, protected these cells from ER stress. This study demonstrated that CO selectively activates PERK for cell survival signaling during ER stress [48] . A recent study has reported that HO-1, dependent on PERK activation during ER stress, can promote mitochondrial biogenesis [28] . Taken together, these studies suggest that the cellular HO-1/CO system relays activation of the PERK branch of the ER stress response to cell survival signals from mitochondria, via inter-organellar communication between the ER and mitochondria. In this study, we sought to determine whether CO-induced activation of the PERK/eIF2α/ATF4 pathway can induce the expression of Sesn genes, which are important negative regulators of both ROS and mTORC1-dependent signaling pathways. Sestrins are a family of highly conserved proteins that are induced upon various conditions of stress, including ER stress. Sestrin proteins are composed of three members (SESN1/2/3) in mammals have versatile biological functions. In addition to known anti-oxidative activities, sestrins also display oxidoreductase-independent functions, including the activation of AMPK and inhibition of mTORC1, which collectively result in the activation of autophagy. As AMPK and mTORC1 represent important kinases in the regulation of metabolic homeostasis, sestrins may represent potential therapeutic targets in metabolic diseases such as NAFLD [19] . In the present study, we investigated whether CO could induce hepatic SESN2 in vitro and in vivo. We found that CO increases the expression of SESN2 in hepatocytes and in liver tissue dependent on the PERK/eIF2α/ATF4 pathway. In vitro experiments revealed that CO-induced SESN2 expression was abrogated in PERK-deficient MEFs, eIF2α
A/A mutant hepatocytes and ATF4-deficient hepatocytes. In vivo, CO inhalation in mice resulted in the induction of SESN2 expression in the liver; whereas increased expression of SESN2 by CO was not observed in the liver of eIF2α A/A mutant mice.
These results suggest that upregulation of SESN2 upon CO treatment requires PERK-mediated signal transduction. Recently, increased SESN2 expression was shown to positively regulate autophagy through activating AMPK and/or inhibiting mTORC1 activity [49, 50] , which contributed to the efficient elimination of damaged cellular organelles [17, 44] . Our results demonstrate that CO-induced SESN2 expression increases AMPK activation, resulting in mTOR inhibition and activation of autophagy. Knockdown of Sesn2 abolished these effects, confirming that CO-mediated autophagy induction occurred in a SESN2-dependent manner. NAFLD, the hepatic manifestation of metabolic syndrome, is an emerging public health concern worldwide. A progressive form of NAFLD is the most common cause of chronic liver disease. Numerous studies have suggested a two-hit hypothesis for NAFLD progression whereby an initial metabolic disturbance causes hepatic steatosis and a second pathogenic stimulus causes oxidative stress, lipid peroxidation, and inflammation, resulting in non-alcoholic steatohepatitis (NASH) [51] . In response to excess caloric intake and sedentary lifestyle, surplus lipids are deposited in hepatocytes resulting in hepatic steatosis. NASH may develop through increasing hepatic inflammation and/or oxidative damage to steatotic liver, leading to hepatic fibrosis, hepatocellular carcinoma, and eventually death [52, 53] . Although CO has been reported to attenuate MCD-mediated NASH [54] , the mechanism by which CO can ameliorate the severity of the abnormalities is unknown. Given the induction of SESN2 by CO, we investigated the involvement of SESN2 in the reduction of NASH by CO treatment. In this study, we utilized the MCD-fed animal model to determine the effects of CO on NASH. The livers of MCD-fed mice exhibited inflammatory cell infiltration, hepatic fat accumulation and hepatic TG concentration. Our results showed that MCD diet caused hepatic TG elevation, liver damage and inflammation in mice, while CO markedly alleviated levels of plasma AST, ALT, hepatic TG and inflammatory cytokines. These data suggest that CO treatment resulted in effective increase of SESN2 expression in MCD-diet fed mice, which induced lipid droplet clearance by promoting autophagy via activation of AMPK and inhibition of mTOR. In addition, knockdown of SESN2 expression in a cellular NASH model blocked the suppressive effect of CO on MCD-induced cellular TG levels, and decreased AMPK activation, mTOR inhibition and autophagy activation induced by CO. Hence, we suggest that CO ameliorates MCD-induced hepatic steatosis by inducing hepatic autophagy via the upregulation of the SESN2/AMPK axis and downregulation of mTOR signaling. In summary, our results demonstrate that therapeutic application of CO has a positive effect on attenuating intrahepatic lipid accumulation, inflammation in the MCD diet-induced NASH model. The induction of autophagy by CO leads to a reduction of hepatic lipid accumulation triggered by MCD diet via modulation of SESN2/AMPK/mTOR signaling. These results suggest that activation of autophagy by CO is a potentially effective strategy to prevent the progression of NAFLD.
Conclusion
Carbon Monoxide induces sestrin-2 expression and alleviates hepatic steatosis in MCD-induced NAFLD. CO leads to an increased sestrin-2 expression through PREK-eIF2a-ATF pathway. CO-induced sestrin-2 upregulation contributes to autophagy induction through activation of AMPK and inhibition of mTORC1. Thus, activation of autophagy by CO is a potentially effective strategy to prevent the progression of NAFLD. Cell lysates were subjected to immunoblotting to detect the expression of SESN2, LC3B, p-AMPK, pp70S6K (T389), and p-Ulk (S757). β-actin was the standard. (E) AML12 cells were transfected with control siRNA (scRNA) or Sesn2-specific siRNA (siSESN2). After 24 h, cells were incubated with MCD medium and then treated with CORM2 (20 μM) for 6 h. Cells lysates were subjected to immunoblotting to detect the expression of SESN2, LC3B, p-AMPK, p-p70S6K (T389), p-Ulk (S757) and β-actin. (F) AML12 cells were transfected with scRNA or Sesn2-specific siRNA (siSESN2). After 24 h, cells were incubated with MCD medium and then treated with CORM2 (20 μM) for 24 h. Cells were harvested and TG content was determined. (G) AML12 cells were co-transfected with pEGFP-LC3 plasmid and scRNA or Sesn2-siRNA in MCD medium. After 36 h, cells were treated with CORM2 (20 μM) for 4 h and then fixed and analyzed for LC3 puncta (green) using a confocal fluorescence microscope. Nuclei were stained with DAPI (blue). The number of LC3B puncta per cell was calculated in 20 randomly chosen cells. Data represent the mean ± SEM. ***P < 0.001.
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